Company intelligence / Profile preview

DK Pierce

Zionsville, Indiana, United Statesdkpierce.net ↗

Ownership: Private
Employees: ~25
Development stage: Other

Overview

DK Pierce specializes in strategic reimbursement and market access solutions for biopharmaceutical companies developing rare disease, oncology, cell and gene therapies. The company does not develop its own therapeutics but partners with drug developers to support commercialization readiness and patient access through data-driven insights, payer intelligence, coding support, operational training, and clinical strategy. It has over two decades of experience in the field.

Therapeutic areas: OncologyRare DiseasesOther
Modalities: Small molecule (consulting focus)Biologic (consulting focus)Gene therapy (consulting focus)Cell therapy (consulting focus)
Industry: Consulting

Beyond the preview

Go deeper on DK Pierce.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DK Pierce.

Explore the full profile